2020 Gastric Cancer Symposium (RP2002K)
Despite decreasing overall incidence of gastric cancer in the United States, the incidence of gastric cancer remains high and actually is increasing in certain populations. The heterogeneity of the disease makes management complex. We present a comprehensive multidisciplinary approach to the evaluation and management of gastric cancer that is tailor towards North Texas providers and the unique gastric cancer population that our region treats.
THIS ACTIVITY IS INTENDED FOR PROVIDERS IN THE SPECIALTIES OF:
- Family Practice
- Internal Medicine
- Oncology (Medical)
- Explain the heterogeneity associated with gastric cancer in terms of presentation, racial/ethnic differences, biologic subtypes, and treatment responsiveness.
- Identify current approaches for early detection, screening, and modification or risk factors.
- Describe current multidisciplinary approaches to the treatment of all stages of gastric cancer.
- Identify various risk factors and pre-malignant conditions which can lead to gastric cancer, including their treatment.
- Explain the role and limitations of various staging modalities for gastric cancer.
- Describe current advancements in the multi-disciplinary treatment of gastric cancer.
Magnitude of the Problem and Diagnosis
Introduction / Welcome
Risk factors: reflux, complex H. pylori, screening
Early detection and treatment of precursor lesions
Crossfire: Barretts, precursor lesion, advanced endoscopic management
(Moderator: Porembka, Panel: Hammer, Suarez, Tavakoli)
Q & A
Break – Coffee
State of the Art Treatment
Advances in Surgical Management
Evolving role of radiation and new technologies
Rapid advances in systemic therapy: chemotherapy and immunotherapy
Crossfire: Resectable gastric cancer – highlight the staging considerations (CT, EUS, PET)
Perioperative therapy (FLOT)
Minimally invasive surgery (robot, etc)
(Moderator: Porembka; Panel: Wang, Kazmi, Aguilera, Sanjeevaiah)
Q & A
Break – Box Lunch
Crossfire: Peritoneal disease (need for staging laparoscopy), HIPEC (indications), Palliation (drains, stents, bypass, etc)
(Moderator: Porembka, Panel: Wang, Sanjeeviah/Kazmi, Suarez/Tavakoli, Hardi)
Crossfire: 35 year old with proximal gastric cancer 3 years out from surgery.
Management after a total gastrectomy, Surveillance (nutrition / cancer), Genetics, RD
(Moderator: Porembka; Panel: Wang, Sanjeevaiah/Kazmi, Suarez/Tavakoli, Hardi)
Q & A / Wrap Up
The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Texas Southwestern Medical Center designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity.
- 3.75 AMA
- 3.75 Attendance